In the overall population of luminal breast cancer, we only observed a significant difference in OS with the Ki-67 cut-off of 30% (67 vs 64 months, p = 0.04, HR = 2.76 95% CI [0.89–3.73]). This evidence concerns the gene MKI67 and breast carcinoma.